CN102432614A - Method for synthesizing coelenterazine - Google Patents

Method for synthesizing coelenterazine Download PDF

Info

Publication number
CN102432614A
CN102432614A CN2011103625843A CN201110362584A CN102432614A CN 102432614 A CN102432614 A CN 102432614A CN 2011103625843 A CN2011103625843 A CN 2011103625843A CN 201110362584 A CN201110362584 A CN 201110362584A CN 102432614 A CN102432614 A CN 102432614A
Authority
CN
China
Prior art keywords
compound
coelenterazine
compd
synthesizing
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011103625843A
Other languages
Chinese (zh)
Inventor
蒋小平
余书强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemedir Biopharm-Techco Ltd
Original Assignee
Chemedir Biopharm-Techco Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemedir Biopharm-Techco Ltd filed Critical Chemedir Biopharm-Techco Ltd
Priority to CN2011103625843A priority Critical patent/CN102432614A/en
Publication of CN102432614A publication Critical patent/CN102432614A/en
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention provides a method for synthesizing coelenterazine. The method comprises the following steps of: 1) performing condensation and ring closing on a compound A and a compound B which are taken as raw materials in the presence of pyridine and TiCl4 so as to obtain a compound C; 2) deoxidizing the compound C through hydrogenation reduction to obtain a compound D; 3) demethylating the compound D and pyridine hydrochloride at the temperature of 200 DEG C to obtain a compound E; and 4) performing condensation and ring closing on the compound E and p-hydroxyphenylpyruvic acid to obtain a product G, namely the coelenterazine. The invention has the advantages that: an optimized method for synthesizing the coelenterazine is provided, and the coelenterazine is synthesized through four-step reaction according to a simple and convenient route; and raw materials used in the method are cheap and readily available, the cost is low, experimental steps are simple, the yield of various steps is high, and the method is suitable for industrialized scale-up production.

Description

The compound method of coelenterazine
Technical field
The present invention relates to a kind of compound method of coelenterazine, belong to the biological chemistry synthesis technical field.
Background technology
Coelenterazine (coelenterazine) is a kind of luciferin, can be luminous, and be the substrate of many luciferases and photoprotein, extensively be present in the aquatic organism, in the noclilucence system, occupy important status.Luciferin and luciferase or photoprotein combination are used to study adjusting and the expression of gene in multiple organism always.
Existing coelenterazine technology synthesis step is tediously long, troublesome poeration, and yield is low, and cost is higher, and it is synthetic and be not suitable for suitability for industrialized production to be only applicable to the laboratory.In view of the huge purposes of coelenterazine and the increase day by day of demand, present market supply simultaneously can not satisfy the demands far away, and therefore, seeking the coelenterazine synthetic route of optimizing just becomes the task of top priority.
Summary of the invention
The objective of the invention is to overcome the weak point of prior art, a kind of compound method of simple and easy to do coelenterazine is provided.
The compound method of coelenterazine of the present invention comprises the following steps:
1) be raw material with compd A and compd B, at pyridine and TiCl 4Ring is closed in following condensation, obtains Compound C, reaction process as shown in the formula:
Figure 2011103625843100002DEST_PATH_IMAGE001
2) Compound C obtains Compound D through the hydro-reduction deoxidation, reaction process as shown in the formula:
Figure 227269DEST_PATH_IMAGE002
3) Compound D and pyridine hydrochloride obtain compd E at 200 ℃ of following demethylations, reaction process as shown in the formula:
Figure 2011103625843100002DEST_PATH_IMAGE003
Figure 153637DEST_PATH_IMAGE004
4) compd E and the phenylor pyruvic acid closed ring through condensation obtains product G, i.e. coelenterazine, reaction process as shown in the formula.
The present invention has following technique effect: the invention provides the method for the synthetic coelenterazine of optimization, through four-step reaction, easier route has synthesized coelenterazine; The invention discloses a kind of coelenterazine synthetic method of comparatively optimizing; The present invention is raw materials used cheap and easy to get, and cost is lower, and experimental procedure is simple to operate; And the yield of each step is higher, is suitable for industrial amplification production.
Embodiment
Below in conjunction with embodiment the present invention is further described, but should not limit protection scope of the present invention with this.
Synthesizing of embodiment 1 Compound C
With compd A (90g, 0.493mol) and compd B (9.7g 0.493mol), is dissolved in the pyridine (700mL), stirs down 30min in-10 degree, slowly drips TiCl 4(214 grams 1.13mol) in reaction flask, dropwise, continue to stir 1 hour, and to room temperature, restir 2 hours.Then, reaction solution is poured in the frozen water, and adding Hydrogen chloride, to regulate pH value be about 4, use ethyl acetate extraction, and drying is revolved driedly, must restrain yield 86% by yellow solid 130.Product can directly be put in next step reaction.
Synthesizing of embodiment 2 Compound D
With Compound C (130 grams 0.423mol) are dissolved in the methyl alcohol (1500mL), add Raney Ni (15 gram), under the atmosphere of hydrogen, stir 15 hours, and reaction finishes, suction filtration, gained filtrating is revolved dried, Compound D (115 restrain), yield 93%.
Synthesizing of embodiment 3 compd Es
With Compound D (14g, 0.0481mol) and pyridine hydrochloride (56g 0.484mol) puts into the flask of 250 mL, stirs, and nitrogen protection is in 200 oC reacted 1 hour down.Reaction finishes, pours in the frozen water, and with the EA extraction, drying, column chromatography gets compd E (10 gram), yield 75%.
Embodiment 4 compound G's (coelenterazine) is synthetic
(10 grams, 0.036mol) and to the phenylor pyruvic acid (16.2 grams 0.09mol) are dissolved in the methyl alcohol, in 100 compd E oMethyl alcohol is revolved in C heated and stirred reaction one hour then, and miscellany is in 150 oC reacted one hour down, and reaction finishes, and the miscellany column chromatography gets compound G (coelenterazine) (9.1 grams, yield 60%).

Claims (1)

1. the compound method of coelenterazine is characterized in that, comprises the following steps:
1) be raw material with compd A and compd B, at pyridine and TiCl 4Ring is closed in following condensation, obtains Compound C, reaction process as shown in the formula:
2) Compound C obtains Compound D through the hydro-reduction deoxidation, reaction process as shown in the formula:
Figure 211514DEST_PATH_IMAGE002
3) Compound D and pyridine hydrochloride obtain compd E at 200 ℃ of following demethylations, reaction process as shown in the formula:
Figure 2011103625843100001DEST_PATH_IMAGE003
Figure 33714DEST_PATH_IMAGE004
4) compd E and the phenylor pyruvic acid closed ring through condensation obtains product G, i.e. coelenterazine, reaction process as shown in the formula.
Figure 2011103625843100001DEST_PATH_IMAGE005
CN2011103625843A 2011-11-16 2011-11-16 Method for synthesizing coelenterazine Pending CN102432614A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011103625843A CN102432614A (en) 2011-11-16 2011-11-16 Method for synthesizing coelenterazine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011103625843A CN102432614A (en) 2011-11-16 2011-11-16 Method for synthesizing coelenterazine

Publications (1)

Publication Number Publication Date
CN102432614A true CN102432614A (en) 2012-05-02

Family

ID=45981002

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011103625843A Pending CN102432614A (en) 2011-11-16 2011-11-16 Method for synthesizing coelenterazine

Country Status (1)

Country Link
CN (1) CN102432614A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020061826A1 (en) * 2018-09-26 2020-04-02 深圳华大智造极创科技有限公司 Intermediate of coelenterazine compound and method for synthesizing coelenterazine compound
US11008326B2 (en) 2018-06-29 2021-05-18 International Paper Company Synthesis of coelenterazine
US11078200B2 (en) 2018-06-29 2021-08-03 International Paper Company Synthesis of coelenterazine
CN113264889A (en) * 2021-06-11 2021-08-17 广西师范大学 Method suitable for industrial production and preparation of gefitinib
US11505787B2 (en) 2014-10-16 2022-11-22 International Paper Company Chemiluminescent wetness indicator for absorbent products

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997043267A1 (en) * 1996-05-11 1997-11-20 Kings College London Pyrazines
WO2001087853A1 (en) * 2000-05-17 2001-11-22 Universite Catholique De Louvain Aryl-substituted n,n-heterocyclic compounds, method for their preparation and their use in therapeutics and diagnostics
WO2010090318A1 (en) * 2009-02-09 2010-08-12 チッソ株式会社 Coelenteramide analogs
CN101889095A (en) * 2007-10-29 2010-11-17 珀金埃尔默健康科学有限公司 Methods, reagents and kits for luciferase assay

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997043267A1 (en) * 1996-05-11 1997-11-20 Kings College London Pyrazines
WO2001087853A1 (en) * 2000-05-17 2001-11-22 Universite Catholique De Louvain Aryl-substituted n,n-heterocyclic compounds, method for their preparation and their use in therapeutics and diagnostics
CN101889095A (en) * 2007-10-29 2010-11-17 珀金埃尔默健康科学有限公司 Methods, reagents and kits for luciferase assay
WO2010090318A1 (en) * 2009-02-09 2010-08-12 チッソ株式会社 Coelenteramide analogs

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HISAE KAKOI,等: "IMPROVED SYNTHESIS OF WATASENIA PRELUCIFERIN", 《HEIEROCYCLES》 *
HISAE KAKOI: "Synthesis of 2-Amino-3-benzyl-5-(p-hydroxyphenyl)pyrazine", 《CHEM. PHARM. BULL.》 *
MARTINE KEENAN,等: "Highly efficient and flexible total synthesis of coelenterazine", 《CHEM. COMMUN.》 *
MASAKI KUSE,等: "Novel synthetic route of aryl-aminopyrazine", 《TETRAHEDRON》 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11505787B2 (en) 2014-10-16 2022-11-22 International Paper Company Chemiluminescent wetness indicator for absorbent products
US11008326B2 (en) 2018-06-29 2021-05-18 International Paper Company Synthesis of coelenterazine
US11078200B2 (en) 2018-06-29 2021-08-03 International Paper Company Synthesis of coelenterazine
US11926624B2 (en) 2018-06-29 2024-03-12 International Paper Company Synthesis of coelenterazine synthesis intermediate
US11939332B2 (en) 2018-06-29 2024-03-26 International Paper Company Synthesis of coelenterazine
WO2020061826A1 (en) * 2018-09-26 2020-04-02 深圳华大智造极创科技有限公司 Intermediate of coelenterazine compound and method for synthesizing coelenterazine compound
CN113264889A (en) * 2021-06-11 2021-08-17 广西师范大学 Method suitable for industrial production and preparation of gefitinib
CN113264889B (en) * 2021-06-11 2023-08-08 广西师范大学 Method suitable for industrial production and preparation of gefitinib

Similar Documents

Publication Publication Date Title
CN102432614A (en) Method for synthesizing coelenterazine
CN108047055B (en) Method for synthesizing deuterated methylamine salt by using halogenated deuterated methane
CN103641722B (en) A kind of production method of adjacent nitro bromobenzyl
CN102408437A (en) Preparation method for Aspoxicillin
CN102304099A (en) Improved method for synthesizing 2-mercaptobenzothiazole derivative
CN102850325A (en) Preparation method of Dabigatran etexilate key intermediate
CN107365262B (en) A kind of preparation method of 5,5- dimethyl -2- cyano cyclopentanone
CN101875640B (en) Method for preparing pyrazinecarboxylic acid in ionic liquid
CN103012432A (en) Method for preparing hydrochloride of high purity cefotiam midbody
CN108794337A (en) A kind of new preparation process of 3,4- dihydroxy-beta-nitrostyrene
CN109096091A (en) The preparation method of cinnamic acid
CN105294678A (en) 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1H, 5H-benzo-quinoline-2-carboxylic acid preparation method
CN104059075B (en) 8,9-is mono-, disubstituted imidazoles [1,2-c]-quinazoline-3 (2H)-one fused heterocyclic compound and preparation method thereof
Cheng et al. Structural study and fluorescent property of a novel organic microporous crystalline material
CN104496900A (en) Method for preparing 2-methoxy-6-one-5,7,8-trihydro-quinoline
CN108794317A (en) The preparation method of 2,3- dimethoxy benzaldehydes
CN108863773A (en) The preparation method of 3- methoxy cinnamic acid
CN104098529B (en) Inorganic metal sulfide promotes the method for dithiocarbonic anhydride and adjacent halobenzene amine Reactive Synthesis 2-mercaptobenzothiazole
CN102424651A (en) Preparation method of 2,7-diacetoxy-9-fluorenone and 2,7-dyhydroxyl-9-fluorenone
CN105837521A (en) 2, 7- dibromo-1, 3, 4, 6, 8, 9-hexafluorophenazine and crystal form and preparation method thereof
CN108929228A (en) A kind of new preparation process of 3- methoxyl group-beta-nitrostyrene
CN102464623B (en) Preparation method for 1, 4- diazacyclooctane-6-formic ester derivative
CN108929229A (en) A kind of new preparation process of the chloro- beta-nitrostyrene of 4-
CN111662233B (en) Method for synthesizing 4-chloro-1H-imidazole-2-carboxylic acid ethyl ester by one-step method
CN107043384B (en) Two furans [3,2-c:2 ', 3 '-i] [1,10] phenanthroline class compound and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20120502